James J Collins Selected Research

James J Collins Research Topics

Disease

22	Neoplasms (Cancer) 01/2021 - 06/2004
14	Infections 10/2021 - 07/2007
3	Bacterial Infections (Bacterial Infection) 01/2018 - 06/2013
3	Leukemia 01/2018 - 10/2004
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2020
2	Reinfection 01/2022 - 12/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022 - 01/2020
2	Schistosomiasis (Bilharziasis) 01/2020 - 10/2019
2	Paralysis (Palsy) 01/2020 - 10/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 10/2009
2	Occupational Asthma 12/2017 - 12/2017
2	Neuroblastoma 01/2016 - 10/2012
2	Communicable Diseases (Infectious Diseases) 01/2015 - 09/2011
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2014 - 11/2010
2	Shock 08/2013 - 03/2012
2	Lung Neoplasms (Lung Cancer) 03/2013 - 06/2004
2	Chloracne 02/2008 - 01/2006
1	Coinfection 01/2022
1	Dysbiosis 01/2022
1	COVID-19 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Malaria 10/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Clostridium Infections 01/2018
1	Dengue (Dengue Fever) 01/2018
1	Cholera 01/2018
1	Escherichia coli Infections 12/2017
1	Asthma (Bronchial Asthma) 12/2017
1	Persistent Infection 09/2017
1	Genomic Instability 09/2017
1	Anemia 05/2016
1	Ileus 01/2016
1	Inflammation (Inflammations) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Carcinogenesis 01/2016
1	Carcinoma (Carcinomatosis) 09/2015
1	Epidermolysa bullosa simplex and limb girdle muscular dystrophy 02/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2015
1	Breast Neoplasms (Breast Cancer) 12/2014
1	Hemangiosarcoma (Angiosarcoma) 11/2014
1	Parkinson Disease (Parkinson's Disease) 09/2014
1	Hematologic Diseases (Blood Diseases) 06/2014
1	Disease Progression 01/2014
1	Tendinopathy (Tendonitis) 07/2013
1	Ototoxicity 07/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2013
1	Urinary Tract Infections (Urinary Tract Infection) 06/2013

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2011
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2013
5	Formaldehyde (Formol)FDA Link 01/2014 - 06/2004
4	Polychlorinated Dibenzodioxins (TCDD)IBA 10/2018 - 06/2009
4	AcrylonitrileIBA 12/2008 - 06/2004
3	Styrene (Styrol)IBA 01/2021 - 03/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2018
2	Praziquantel (Biltricide)FDA Link 01/2020 - 10/2019
2	Messenger RNA (mRNA)IBA 01/2018 - 08/2012
2	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 12/2017 - 12/2017
2	AminoglycosidesIBA 02/2017 - 07/2013
2	MicroRNAs (MicroRNA)IBA 01/2016 - 08/2012
2	Small Interfering RNA (siRNA)IBA 09/2015 - 01/2014
2	Benzene (Benzole)IBA 02/2015 - 10/2004
2	CarcinogensIBA 01/2014 - 10/2004
2	indoleIBA 08/2013 - 03/2012
2	DioxinsIBA 10/2009 - 01/2006
2	Hazardous Waste (Hazardous Wastes)IBA 02/2008 - 08/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2022
1	Sialic AcidsIBA 10/2021
1	Drug CombinationsIBA 01/2021
1	SU 3327IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	AlkaloidsIBA 10/2019
1	Nucleic AcidsIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2017
1	Glutathione (Reduced Glutathione)IBA 09/2017
1	Erythropoietin FDA Link 05/2016
1	CytokinesIBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	LipopolysaccharidesIBA 01/2016
1	EndotoxinsIBA 01/2016
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2016
1	PlectinIBA 02/2015
1	Vinyl Chloride (Chloroethylene)IBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014
1	Estrogens (Estrogen)FDA Link 01/2014
1	QuinolonesIBA 07/2013
1	LactamsIBA 07/2013
1	SilverIBA 06/2013
1	Vancomycin FDA LinkGeneric 06/2013

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2006
2	Transplantation 01/2020 - 09/2017
1	Organ Transplantation 01/2020
1	Mass Drug Administration 10/2019
1	Oral Administration 01/2018
1	RNAi Therapeutics 01/2014